TY - JOUR
T1 - Correlation of radionuclide estimates of myocardial infarction size and release of creatine kinase-MB in man
AU - Morrison, J.
AU - Coromilas, J.
AU - Munsey, D.
AU - Robbins, M.
AU - Zema, M.
AU - Chiaramida, S. U.
AU - Reiser, P.
AU - Scherr, L.
PY - 1980
Y1 - 1980
N2 - Creatine kinase-MB isoenzyme release (CK-MB-g-Eq) was correlated with left ventricular (LV) radionuclide gated blood pool wall motion estimates of percent abnormally contracting regions (%ACR), ejection fraction (EF) and quantitative thallium-201 (Tl-201) LV perfusion scintigraphy (TI-201 perfusion index) during evolving myocardial infarction (MI). Of the 35 patients, 14 had no evidence of either prior MI or right ventricular (RV) MI, and the CK-MB-g-EQ showed reasonable correlation with %ACR (r=0.72; SEE=18.28), with EF (r = -0.78; SEE=0.07) and with the Tl-201 perfusion index (r=0.65; SEE=7.93). In the six patients with prior MI there was no significant correlation between CK-MB-g-Eq and %ACR, EF or Tl-201 perfusion index. Eight other patients had a RVEF that was less than one-half of the LVEF, as well as regional RV wall motion abnormalities, suggesting a combination of LV and RV necrosis. In these patients, there was no significant correlation between CK-MB-g-Eq and %ACR, LVEF or Tl-201 perfusion index. In seven patients with two peaks to their CK-MB release curve, before CK-MB returned to baseline, CK-MB-g-Eq was associated with early %ACR (r=0.71; SEE=21.06), EF (r=-0.81; SEE=0.14) and with the early Tl-201 perfusion index (r=0.78; SEE=6.46), suggesting either that small extensions are beyond the resolution of the radionuclide assessment techniques used in this study or that these patients represent a variant CK-MB release pattern unassociated with extension. These independent radionuclide and enzymatic data suggest that radionuclide techniques may be a reliable clinical method for assessing the extent of LV necrosis during MI. However, limitations may exist in certain cases when either concurrent RV necrosis or prior MI are present.
AB - Creatine kinase-MB isoenzyme release (CK-MB-g-Eq) was correlated with left ventricular (LV) radionuclide gated blood pool wall motion estimates of percent abnormally contracting regions (%ACR), ejection fraction (EF) and quantitative thallium-201 (Tl-201) LV perfusion scintigraphy (TI-201 perfusion index) during evolving myocardial infarction (MI). Of the 35 patients, 14 had no evidence of either prior MI or right ventricular (RV) MI, and the CK-MB-g-EQ showed reasonable correlation with %ACR (r=0.72; SEE=18.28), with EF (r = -0.78; SEE=0.07) and with the Tl-201 perfusion index (r=0.65; SEE=7.93). In the six patients with prior MI there was no significant correlation between CK-MB-g-Eq and %ACR, EF or Tl-201 perfusion index. Eight other patients had a RVEF that was less than one-half of the LVEF, as well as regional RV wall motion abnormalities, suggesting a combination of LV and RV necrosis. In these patients, there was no significant correlation between CK-MB-g-Eq and %ACR, LVEF or Tl-201 perfusion index. In seven patients with two peaks to their CK-MB release curve, before CK-MB returned to baseline, CK-MB-g-Eq was associated with early %ACR (r=0.71; SEE=21.06), EF (r=-0.81; SEE=0.14) and with the early Tl-201 perfusion index (r=0.78; SEE=6.46), suggesting either that small extensions are beyond the resolution of the radionuclide assessment techniques used in this study or that these patients represent a variant CK-MB release pattern unassociated with extension. These independent radionuclide and enzymatic data suggest that radionuclide techniques may be a reliable clinical method for assessing the extent of LV necrosis during MI. However, limitations may exist in certain cases when either concurrent RV necrosis or prior MI are present.
UR - http://www.scopus.com/inward/record.url?scp=0018963715&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0018963715&partnerID=8YFLogxK
U2 - 10.1161/01.CIR.62.2.277
DO - 10.1161/01.CIR.62.2.277
M3 - Article
C2 - 7397970
AN - SCOPUS:0018963715
SN - 0009-7322
VL - 62
SP - 277
EP - 287
JO - Circulation
JF - Circulation
IS - 2
ER -